Physician profile
Daniel Haimowitz
NPI 1013064377
$15,478.74
in general payments reported to CMS, 2019-2025
29 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 91% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,395 · 2020: $127 · 2021: $175 · 2022: $1,034 · 2023: $2,047 · 2024: $3,504 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Consulting Fee: $1,740 · Food and Beverage: $867 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $622 · Travel and Lodging: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Consulting Fee | $1,740.00 |
| Food and Beverage | $866.88 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $621.95 |
| Travel and Lodging | $270.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $7,267.56 | 2019-2025 | Nuplazid |
| Intuitive Surgical, INC. | $2,516.99 | 2024 | |
| Merck Sharp & Dohme LLC | $1,740.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $947.07 | 2022-2023 | |
| Pfizer INC. | $931.20 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $750.00 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $258.17 | 2023-2025 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $124.83 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $119.59 | 2019-2020 | |
| Lundbeck LLC | $116.19 | 2023-2025 | Rexulti |
| Astrazeneca Pharmaceuticals Lp | $96.50 | 2021-2025 | Farxiga, Airsupra |
| Almatica Pharma LLC | $82.57 | 2024-2025 | Loreev Xr, Teriparatide |
| Novartis Pharmaceuticals Corporation | $61.64 | 2019-2023 | |
| Biogen, INC. | $46.06 | 2020-2021 | |
| Corium, LLC | $45.78 | 2022-2023 | Adlarity |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $42.08 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $38.01 | 2024 | Opsumit |
| Smith+Nephew, INC. | $35.29 | 2022-2023 | Collagenase Santyl |
| Lilly USA, LLC | $33.33 | 2025 | Mounjaro |
| Neurocrine Biosciences, INC. | $32.39 | 2025 | |
| Abbvie INC. | $30.98 | 2024 | |
| Philips North America LLC | $29.18 | 2021 | |
| Bausch Health US, LLC | $27.33 | 2019-2020 | |
| Genentech USA, INC. | $22.30 | 2025 | Xolair |
| Eisai INC. | $19.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.00 | 2019 | |
| Neurelis, INC. | $16.74 | 2023 | Valtoco |
| Amarin Pharma, INC. | $15.23 | 2019 | |
| Cook Medical LLC | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Haimowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.